| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.36B | +12.5% | +133.7% |
| Cost of Revenue | $368.8M | +18.0% | +157.7% |
| R&D Expense | $93.0M | +16.3% | +564.3% |
| SG&A Expense | $151.9M | -12.8% | +351.6% |
| Operating Income | $51.9M | +169.9% | -55.7% |
| Interest Expense | $283.4M | +10.6% | +177.0% |
| Pre-tax Income | -$236.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.89B | +64.3% | +39.8% |
| Short-term Investments | $47.4M | — | — |
| Accounts Receivable | $1.66B | -14.2% | — |
| Current Assets | $4.73B | +19.9% | — |
| Total Assets | $32.91B | +25.4% | — |
| Current Liabilities | $9.71B |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.50B | — | — |
| Capital Expenditures | $6.25B | — | — |
| Investing Cash Flow | -$6.35B | — | — |
| Financing Cash Flow | $5.78B | — | — |
| Free Cash Flow | -$4.75B | — | — |
| +2.4% |
| +25.6% |
| Income Tax | -$126.7M | -365.2% | -404.1% |
| Net Income | -$110.1M | +62.1% | +69.4% |
| EPS (Basic) | -$0.22 | +63.3% | +87.9% |
| EPS (Diluted) | -$0.22 | +63.3% | +87.9% |
| +28.6% |
| — |
| Long-term Debt | $14.03B | +27.0% | — |
| Total Liabilities | $29.03B | +29.5% | — |
| Stockholders' Equity | $3.88B | +45.9% | +1227.2% |